Available Programs

Leveraging Evolving Data to Inform Treatment in HR-Positive, HER2-Negative Advanced Breast Cancer

Join us for this dynamic, CME/MOC-certified symposium on the optimal treatment of patients with HR-positive, HER2-negative advanced breast cancer, featuring review and discussion of key clinical data and patient case studies by a panel of renowned breast cancer experts as well as a look ahead at promising agents in the setting of endocrine therapy–pretreated disease that may soon change practice.

Sign up now! Registration is complimentary.

Held in conjunction with SABCS® 2019

2 upcoming events, beginning 12/11/2019More Information

Practical Application of Immuno-Oncology in Renal Cell Carcinoma

Expert discussion of current best practices for using immunotherapy in the treatment of patients with renal cell carcinoma.

Not an official event of the 2020 Genitourinary Cancers Symposium. Not sponsored, endorsed, or accredited by ASCO or the Conquer Cancer Foundation.

2 upcoming events, beginning 02/13/2020More Information

Advances in Hemophilia A: Expert Guidance and Practical Case Discussions

Join us for this live, CME-certified symposium featuring review and discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the treatment of hemophilia.

You will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

There are no upcoming events, please check back soon.

Advancing the Role of BTK Inhibitors in B-Cell Malignancies: Expert Guidance for Clinical Management

Join us for this live, CME-certified symposium featuring review and discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the use of Bruton’s tyrosine kinase (BTK) inhibitors to treat mantle cell lymphoma, chronic lymphocytic leukemia, and other B-cell malignancies

You will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

There are no upcoming events, please check back soon.

AML: Expert Guidance on Current Standards and New Directions in Patient Care

Join us for this live, CME-certified symposium featuring review and discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the treatment of AML.

You will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

There are no upcoming events, please check back soon.

Approaches To Achieve the Best Possible Outcomes in Myeloma

Join us for this live, CME-certified symposium featuring discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the treatment of multiple myeloma. You will get practical insights from experts as they discuss their personal approaches for myeloma care.

You will also have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Sign up now! Registration is complimentary.

IMF Livestream: https://www.myeloma.org/IMF-ASH-Orlando

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

There are no upcoming events, please check back soon.

Approaches to Personalized Treatment for CLL: Expert Guidance on Sequencing Therapy and Novel Agents

Join us for this live, CME-certified symposium featuring review and discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the personalized treatment of patients with CLL.

You will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

There are no upcoming events, please check back soon.

Approaches to the Individualized Management of MPNs: Best Practices and Guidance to Optimize Care

Join us for this live, CME-certified symposium featuring review and discussion of patient case studies and key clinical trial data by renowned clinical experts providing their perspectives on recent advances in the treatment of myeloproliferative neoplasms.

You will have multiple opportunities to interact with faculty through interactive patient case scenarios and dynamic question and answer sessions.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

There are no upcoming events, please check back soon.

CAR T-Cell Therapy for Leukemia, Lymphoma, and Myeloma: Where We Are and Where We Are Going

Join us for this dynamic, CME-certified symposium! Led by Stephen J. Schuster, MD, an expert panel will reveal how they currently use CAR T-cells to treat leukemia, lymphoma, and myeloma, and provide a look ahead at new data and promising agents that may soon change practice.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

There are no upcoming events, please check back soon.

New Directions in Treating Peripheral T-Cell Lymphomas: Expert Guidance and Case Discussions

Join us for this dynamic, CME-certified symposium! Led by Steven M. Horwitz, MD, an expert panel will reveal how they approach current therapeutic decisions for their patients with PTCL and provide a look ahead at new data and promising agents that may soon change practice.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

There are no upcoming events, please check back soon.

β-Thalassemia: Expert Insights on New Therapies for an Old Disease

Join us for this dynamic, CME-certified symposium! Led by Maria Domenica Cappellini, MD, an international panel will reveal how experts approach current therapeutic decisions for their patients with β-thalassemia and provide a look ahead at new data and promising agents that may soon change practice.

Sign up now! Registration is complimentary.

Friday Satellite Symposium preceding the 61st ASH Annual Meeting & Exposition.

There are no upcoming events, please check back soon.

Optimizing the Clinical Application of CAR T-Cell Therapy: Best Practices for the Community Setting

Interact with peers while gaining expert insight on how to best use CAR T-cells in the treatment of lymphomas and leukemias in this interactive, case-based 1-hour live meeting. The latest clinical data will be highlighted, as well as expert treatment options from CCO’s online CAR T-cell toxicity management tool. After the meeting, download the associated slideset for use in your clinic.

Register Now!

1 upcoming events, beginning 01/07/2020More Information

Expert Guidance on the Expanding Role of Immunotherapy in HNSCC: A Live Workshop Series

Learn how to utilize immune checkpoint inhibitors for HNSCC treatment to improve outcomes for your patients with these expert-led 1-hour case-based workshops.

There are no upcoming events, please check back soon.

Shared Decision Making and the Current Landscape of Checkpoint Inhibitor Therapy in Metastatic NSCLC

Interact with your peers while gaining expert insight on how to best use immune checkpoint inhibitors for the treatment of advanced NSCLC in this 1-hour, expert-led, case-based workshop. The latest clinical data will be highlighted as will guidance on individualizing therapy with input from patients.

There are no upcoming events, please check back soon.